{"id":"td-vaccine-system","safety":{"commonSideEffects":[{"rate":null,"effect":"Pain, redness, or swelling at the injection site"}]},"_chembl":{"chemblId":"CHEMBL2108573","moleculeType":"Vaccine component"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"This is achieved through the administration of a vaccine that stimulates the body's immune system to produce antibodies and immune cells that can recognize and fight specific pathogens. The vaccine contains antigens that are derived from the pathogens, which are then processed by the immune system to trigger an immune response.","oneSentence":"The TD Vaccine System induces an immune response against specific pathogens.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:37:47.265Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Protection against certain infectious diseases"}]},"trialDetails":[{"nctId":"NCT03334305","phase":"PHASE1","title":"Adoptive Cellular Therapy in Pediatric Patients With High-grade Gliomas","status":"TERMINATED","sponsor":"University of Florida","startDate":"2018-05-16","conditions":"Malignant Glioma, High Grade Glioma","enrollment":18},{"nctId":"NCT05096481","phase":"PHASE2","title":"PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma","status":"RECRUITING","sponsor":"Nationwide Children's Hospital","startDate":"2024-07-18","conditions":"High Grade Glioma, Diffuse Intrinsic Pontine Glioma, Recurrent Medulloblastoma","enrollment":120},{"nctId":"NCT01868334","phase":"NA","title":"SOP Toolkit in Diverse Practices Implemented & Tested With RE-AIM","status":"COMPLETED","sponsor":"University of Pittsburgh","startDate":"2013-04","conditions":"Adult Influenza Vaccinations, Adult PPSV Vaccinations, Adult Tdap/Td Vaccinations","enrollment":70549},{"nctId":"NCT00006066","phase":"PHASE1","title":"Interleukin-2 Plus Anti-HIV Therapy in HIV-Infected Children With Weakened Immune Systems","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"","conditions":"HIV Infections","enrollment":92},{"nctId":"NCT00565461","phase":"PHASE2","title":"LT Vaccine Patch Self-Administration Study","status":"COMPLETED","sponsor":"Intercell USA, Inc.","startDate":"2007-11","conditions":"Prevention of Travelers' Diarrhea","enrollment":160},{"nctId":"NCT00751777","phase":"PHASE2","title":"Traveler's Diarrhea (TD) Automated Process","status":"COMPLETED","sponsor":"Intercell USA, Inc.","startDate":"2008-09","conditions":"Prevention of Travelers' Diarrhea","enrollment":120},{"nctId":"NCT01390363","phase":"NA","title":"Study of Adolescent Immunization Recall Systems","status":"COMPLETED","sponsor":"Boston Children's Hospital","startDate":"2010-05-01","conditions":"Immunization, Reminder Systems","enrollment":420},{"nctId":"NCT01339000","phase":"PHASE2","title":"Improving the Immune System With Human IL-7 Vaccine in Older Subjects Who Have Had Chemotherapy","status":"TERMINATED","sponsor":"National Cancer Institute (NCI)","startDate":"2011-04","conditions":"Breast Cancer, Colon Cancer, Bladder Cancer","enrollment":1},{"nctId":"NCT00993681","phase":"PHASE3","title":"Travelers' Diarrhea (TD) Vaccine Pivotal Efficacy Study","status":"COMPLETED","sponsor":"Intercell USA, Inc.","startDate":"2009-10","conditions":"Travelers' Diarrhea","enrollment":2036},{"nctId":"NCT01040325","phase":"PHASE2","title":"Traveler's Diarrhea (TD) Vaccine Asia Efficacy Study","status":"COMPLETED","sponsor":"Intercell USA, Inc.","startDate":"2009-12","conditions":"Traveler's Diarrhea","enrollment":723}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":5,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"TD Vaccine System","genericName":"TD Vaccine System","companyName":"Intercell USA, Inc.","companyId":"intercell-usa-inc","modality":"Biologic","firstApprovalDate":"","aiSummary":"The TD Vaccine System induces an immune response against specific pathogens. Used for Protection against certain infectious diseases.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}